International Journal For Multidisciplinary Research

E-ISSN: 2582-2160     Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 6 Issue 4 July-August 2024 Submit your research before last 3 days of August to publish your research paper in the issue of July-August.

1,3,4-Oxadiazole as an Anticancer Agent

Author(s) Vaishnavi Chopade, Vinayak Gaware
Country India
Abstract The modern era's fastest-growing disease is cancer, it poses a serious threat to people's lives. For the treatment of various cancers, the FDA has approved a number of medications. However, because of the rise in drug toxicity incidents, there is a continual need for the discovery of novel anti-cancer drugs. Five-membered heterocyclic ring with multifaceted biological action is the 1,3,4-oxadiazole. Their anti-proliferative actions are linked to a number of processes, including the inhibition of kinases, enzymes, and growth factors. Numerous 1,3,4-oxadiazoles have been found to be effective anticancer agents for a variety of cancer cell types. Oxadiazoles may target the NF-kB signalling system to exert their anti-cancer effects, according to certain reports. This study examines the importance of the 1,3,4-oxadiazole ring structure and how it can function as a model for a new anticancer drug. This in-depth analysis focuses on the research on 1,3,4-oxadiazole as a cancer preventative.
Keywords 1,3,4-oxadiazole , Anticancer activity, Antiproliferative action , Cytostatic activity, Antitumoral activity , Biological evaluation , Anticancer agents
Field Chemistry > Pharmacy
Published In Volume 6, Issue 3, May-June 2024
Published On 2024-06-27
Cite This 1,3,4-Oxadiazole as an Anticancer Agent - Vaishnavi Chopade, Vinayak Gaware - IJFMR Volume 6, Issue 3, May-June 2024. DOI 10.36948/ijfmr.2024.v06i03.23386
DOI https://doi.org/10.36948/ijfmr.2024.v06i03.23386
Short DOI https://doi.org/gt24zr

Share this